Total Payments
$1,321
2024 Payments
$351.13
Companies
10
Transactions
52
Medicare Patients
10,059
Medicare Billing
$3.3M
Payment Breakdown by Category
Food & Beverage$1,304 (98.7%)
Education$17.19 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,304 | 51 | 98.7% |
| Education | $17.19 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $746.93 | 23 | $0 (2024) |
| Genentech USA, Inc. | $312.68 | 16 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $63.35 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $51.26 | 2 | $0 (2019) |
| Sun Pharmaceutical Industries Inc. | $31.89 | 2 | $0 (2019) |
| Alimera Sciences, Inc. | $26.16 | 1 | $0 (2024) |
| Thea Pharma Inc. | $24.38 | 1 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $23.59 | 1 | $0 (2022) |
| Shire North American Group Inc | $22.03 | 1 | $0 (2018) |
| Johnson & Johnson Surgical Vision, Inc. | $19.01 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $351.13 | 13 | Regeneron Healthcare Solutions, Inc. ($208.21) |
| 2023 | $524.82 | 21 | Regeneron Healthcare Solutions, Inc. ($290.60) |
| 2022 | $196.06 | 7 | Regeneron Healthcare Solutions, Inc. ($123.04) |
| 2021 | $67.99 | 3 | Regeneron Healthcare Solutions, Inc. ($67.99) |
| 2020 | $29.82 | 1 | Regeneron Healthcare Solutions, Inc. ($29.82) |
| 2019 | $80.17 | 4 | Sun Pharmaceutical Industries Inc. ($31.89) |
| 2018 | $52.28 | 2 | Novartis Pharmaceuticals Corporation ($30.25) |
| 2017 | $19.01 | 1 | Johnson & Johnson Surgical Vision, Inc. ($19.01) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/09/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Ophthalmology | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $37.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/19/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/10/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/30/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Ophthalmology | ||||||
| 09/30/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $37.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/10/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/12/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/06/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $101.35 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/01/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/01/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $0.36 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/30/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Education | Cash or cash equivalent | $17.19 | General |
| Category: Ophthalmology | ||||||
| 11/09/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/09/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/11/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/26/2023 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/12/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $36.28 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/10/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/04/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 3,075 | 15,185 | $6.7M | $1.2M |
| 2022 | 17 | 2,924 | 6,107 | $6.7M | $1.1M |
| 2021 | 16 | 2,147 | 4,348 | $4.2M | $669,876 |
| 2020 | 14 | 1,913 | 3,374 | $2.6M | $410,892 |
Total Patients
10,059
Total Services
29,014
Medicare Billing
$3.3M
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 140 | 786 | $3.2M | $539,994 | 16.6% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 59 | 8,460 | $482,981 | $245,197 | 50.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 897 | 2,056 | $781,149 | $184,161 | 23.6% |
| 92134 | Imaging of retina | Office | 2023 | 798 | 2,079 | $573,804 | $62,142 | 10.8% |
| 67028 | Injection of drug into eye | Office | 2023 | 156 | 577 | $892,042 | $50,639 | 5.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 124 | 200 | $54,464 | $14,114 | 25.9% |
| 92250 | Photography of the retina | Office | 2023 | 299 | 362 | $132,492 | $10,018 | 7.6% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 28 | 33 | $81,675 | $7,792 | 9.5% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 15 | 29 | $135,778 | $7,719 | 5.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $34,650 | $7,345 | 21.2% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 62 | 63 | $49,896 | $6,394 | 12.8% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 25 | 29 | $113,332 | $5,277 | 4.7% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 143 | 158 | $12,324 | $2,853 | 23.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 39 | 44 | $22,572 | $1,925 | 8.5% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 36 | 47 | $20,586 | $1,808 | 8.8% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 132 | 133 | $6,650 | $1,463 | 22.0% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 15 | 21 | $8,190 | $1,232 | 15.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 25 | 26 | $7,176 | $729.24 | 10.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 14 | 14 | $2,240 | $289.25 | 12.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 160 | 1,024 | $4.2M | $734,338 | 17.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 845 | 1,602 | $451,764 | $147,221 | 32.6% |
| 92134 | Imaging of retina | Office | 2022 | 721 | 1,699 | $468,924 | $51,410 | 11.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 175 | 548 | $847,208 | $48,006 | 5.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 139 | 215 | $42,140 | $14,083 | 33.4% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2022 | 23 | 56 | $262,192 | $14,065 | 5.4% |
About Dr. Andrew Kopel, MD
Dr. Andrew Kopel, MD is a Ophthalmology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568575140.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Kopel, MD has received a total of $1,321 in payments from pharmaceutical and medical device companies, with $351.13 received in 2024. These payments were reported across 52 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,304).
As a Medicare-enrolled provider, Kopel has provided services to 10,059 Medicare beneficiaries, totaling 29,014 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Houston, TX
- Active Since 08/16/2006
- Last Updated 03/19/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1568575140
Products in Payments
- EYLEA (Biological) $402.00
- EYLEA HD (Biological) $344.93
- Vabysmo (Drug) $263.25
- Syfovre (Drug) $63.35
- VABYSMO (Drug) $49.43
- BROMSITE (Drug) $31.89
- BROLUCIZUMAB (Drug) $30.25
- YUTIQ (Drug) $26.16
- IYUZEH (Drug) $24.38
- VYZULTA (Drug) $23.59
- XIIDRA (Drug) $22.03
- BEOVU (Drug) $21.01
- Blink eye drops $19.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Houston
Stephen Slade, M.d, M.D
Ophthalmology — Payments: $1.5M
Ophthalmology $1.5M
Dr. Christina Weng, M.d., M.b.a, M.D., M.B.A
Ophthalmology — Payments: $635,330
Ophthalmology $635,330
Zaina Al-Mohtaseb, Md, MD
Ophthalmology — Payments: $559,665
Ophthalmology $559,665
Dr. John Micheletti, M.d, M.D
Ophthalmology — Payments: $555,738
Ophthalmology $555,738
David Brown, M.d, M.D
Ophthalmology — Payments: $488,095
Ophthalmology $488,095
Dr. Douglas Koch, M.d, M.D
Ophthalmology — Payments: $457,260
Ophthalmology $457,260